Femtech Insider

𝐖𝐚𝐧𝐭 𝐭𝐨 𝐰𝐨𝐫𝐤 𝐢𝐧 𝐰𝐨𝐦𝐞𝐧'𝐬 𝐡𝐞𝐚𝐥𝐭𝐡? 𝐒𝐭𝐚𝐫𝐭 𝐲𝐨𝐮𝐫 𝐣𝐨𝐛 𝐬𝐞𝐚𝐫𝐜𝐡 𝐭𝐨𝐝𝐚𝐲! 👇 ✨ Every Friday we share a selection of jobs at top companies in the femtech and women's health innovation ecosystem. For more visit jobs.femtechinsider.com. Evvy is looking for a Senior Product Manager. https://lnkd.in/ggkRjBdV Frida is hiring a Supply Planner, International Markets. https://lnkd.in/gGMDYWjX Pomelo Care is looking for a Staff Security Engineer. https://lnkd.in/gqkiHEy3 Herself Health is hiring a Part-Time Medical Assistant. https://lnkd.in/gbxN-rJW Carrot Fertility is hiring a Sr. Sales Operations Analyst. https://lnkd.in/gvSQDKwC Progyny, Inc. is looking for a Legal Intern. https://lnkd.in/gmFpY9Aq Tia is hiring a Phlemotomist (Full-Time). https://lnkd.in/g-sNy9EZ Oula is looking for a Field Marketing Manager. https://lnkd.in/gfcHgd-X #femtech #womenshealth #womenshealthinnovation #digitalhealth #biotech #reproductivehealth #healthcare #jobs #jobsearch #career #health #workinwomenshealth

💰 Future Family has secured a $400 million financing program from Clear Haven Capital Management, LLC to expand financing options for fertility treatments, including IVF and egg-freezing. This "forward flow deal" means Clear Haven Capital Management has committed to purchasing up to $400 million in fertility treatment loans issued by Future Family over time. 🤝 💬 "When we started Future Family, our goal was to make fertility care easier and more accessible—not just by offering financing, but by improving the entire experience. This new funding helps us remove financial barriers so more women and couples can get the fertility treatments they need when they need them. From IVF financing to our new IVF insurance, we're making fertility care more affordable, flexible, and focused on patients." Claire Tomkins, Founder of Future Family More on this: https://lnkd.in/gudmgfBP #femtech #fertility #reproductivehealth #fertilitycare #infertility #financinc #access #healthequity #healthcareinnovation #finance #insurance #ivf

🤔 𝗖𝘂𝗿𝗶𝗼𝘂𝘀 𝘄𝗵𝗮𝘁'𝘀 𝗯𝗲𝗲𝗻 𝘂𝗽 𝗶𝗻 𝘁𝗵𝗲 𝘄𝗼𝗿𝗹𝗱 𝗼𝗳 𝗳𝗲𝗺𝘁𝗲𝗰𝗵 𝗮𝗻𝗱 𝘄𝗼𝗺𝗲𝗻'𝘀 𝗵𝗲𝗮𝗹𝘁𝗵 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗶𝘀 𝘄𝗲𝗲𝗸? 𝗛𝗲𝗿𝗲'𝘀 𝘁𝗵𝗲 𝗼𝘂𝗿 𝗿𝘂𝗻-𝗱𝗼𝘄𝗻! 👇 💰 Women’s healthtech company Fizimed raises €4M for international expansion. 💰 PE Firm Astorg combined multiple reproductive health medtech businesses; launches Nexpring Health. 🤝 Willow Innovations, Inc. acquires Elvie: Femtech leaders join forces. 🤝 Organon acquires arthritis biosimilar from Biogen. 🤝 Rhea Fertility acquires Tilly to enhance mental health support in fertility care. ✅ US Fertility adopts AI embryo imaging technology from Alife. 🤰 Progyny, Inc. expands maternal health services with Pacify doula platform. 🚀 Wildflower Health launches Care Connect to expand maternal health support. 🚀 FDA approves first new UTI antibiotic class in 30 years. ✅ Labcorp introduces self-collection option for HPV and STI testing. 🤝 LOLA partners with WNBA (Women's National Basketball Association) Champions New York Liberty and Barclays Center to provide free organic period care. 🇺🇸 Functional fitness company Pvolve expands brick-and-mortar presence with 10 new studios across the US. Want to learn more about any of the above (and more!)? Check out the round-up post on our blog! 👉 https://lnkd.in/g4fYyAWn #femtech #womenshealth #health #healthtech #healthcareinnovation #digitalhealth #biotech #medtech #medicaldevices #startup #scaleup #vc #research #partnership #ecosystem

🛒 Tesco has launched the UK’s first permanent menopause-friendly product bays, addressing the needs of 15.5 million women navigating menopause. The initiative, developed in collaboration with GenM Official, will roll out across 93 large stores nationwide from April 2025. 🛍️ 💬 "We’re delighted to be continuing our work with GenM to support our customers and colleagues going through the menopause. Following a successful trial last year, we hope that having these permanent menopause-friendly bays in 93 of our large stores will provide reassurance and education as well as helping signpost customers to products that may be safer when going through the menopause or that might ease associated symptoms." Thomas Lye, Category Director for Health and Wellness at Tesco More on this: https://lnkd.in/gNvn9ZtC #femtech #womenshealth #womenshealthinnovation #health #healthcare #retail #uk #menopause #perimenopause #partnership #shopping

💰 Investment in women’s health has reached unprecedented levels, hitting $2.6 billion in 2024 according to the latest report from Silicon Valley Bank. The 2025 Innovation in Women’s Health Report details how funding in the sector surpassed 2023’s total by nearly $1 billion, signaling growing recognition of both the unmet needs and market opportunities in women’s healthcare. 📈 💬 “Investment in women’s health continues to reach new milestones, driven by a growing recognition of the ways in which health conditions impact women differently. While 2025 may present challenges, the long-term potential of the sector is clear, and we expect continued investment focused on addressing the unmet healthcare needs for women.” Raysa Bousleiman, Report Co-author & Vice President for Investor Coverage in Life Science and Healthcare at SVB More on this: https://lnkd.in/gAhXHqGe #femtech #womenshealth #womenshealthinnovation #womenshealthinvestment #investor #vc #pe #venturecapital #privateequity #report #finance #ecosystem #digitalhealth #medtech #biotech #lifesciences #biopharma

🚀 Covera Health has introduced Protect Her, an AI-powered platform designed to enhance early detection of critical health conditions in women aged 40 and older. The innovative solution leverages routine imaging like mammograms, chest CTs, and x-rays to identify early signs of breast cancer, cardiovascular disease, and osteoporosis before symptoms appear. 🏥 💬 “Early detection is the single most powerful tool we have to improve health outcomes, particularly for women, who are frequently underdiagnosed in these areas. Protect Her empowers providers with AI-powered insights that can detect serious and life-threatening conditions early, allowing women to get the right care before it’s too late. This is a game-changer for women’s health.” Ron Vianu, Founder & CEO of Covera Health More on this: https://lnkd.in/gSM8PuTs #femtech #womenshealth #womenshealthinnovation #health #healthtech #healthcare #digitalhealth #healthcareinnovation #breasthealth #breastcancer #hearthealth #launch #company #startup

💰 A new medical device designed to address threatened miscarriage has secured £1 million in funding from the NIHR (National Institute for Health and Care Research) to begin clinical trials. The Callavid device, developed by UK-based Calla Lily Clinical Care, aims to transform how progesterone is delivered to women experiencing threatened miscarriage – potentially helping over 150,000 women each year in the UK alone. If approved, it would become the world’s first drug-device combination product to treat threatened miscarriage. 💬 "Having been through seven rounds of IVF, I have first-hand experience of how awful taking progesterone can be. Any woman who is trying to have a baby knows she will do anything to make sure she is getting the right medications and maximising her chance of success. Vaginal progesterone leaks. Badly. Excessive leakage causes so much additional and unnecessary distress. Our device has significant potential to improve women's quality of life; improving their experience of administering progesterone and playing a role in tackling threatened miscarriage." Lara Zibners MD MMEd MBA, Co-founder and Chair of Calla Lily Clinical Care More on this: https://lnkd.in/guy_CMHf #femtech #womenshealth #womenshealthinnovation #medtech #biotech #healthtech #investment #trial #clinicaltrial #healthcareinnovation #impact #healthcareinnovation #pregnancy #reproductivehealth #uk

🤝 Organon has acquired the regulatory and commercial rights to TOFIDENCE, a biosimilar to ACTEMRA, from Biogen. The first approved tocilizumab biosimilar in the U.S. market, TOFIDENCE was launched in May 2024 and addresses conditions that disproportionately affect women, such as rheumatoid arthritis and juvenile idiopathic arthritis. 🫲 💬 "Biosimilars continue to be a key growth driver for Organon, and this acquisition complements our existing business, enabling us to expand our immunology portfolio," said Kevin Ali, Organon's Chief Executive Officer. "We believe that by leveraging our commercial expertise and market access capabilities, there is considerable growth potential for this product." Kevin Ali, Organon CEO More on this: https://lnkd.in/gZfWDRz9 #femtech #womenshealth #womenshealthinnovation #health #healthcare #arthritis #healthtech #biotech #pharma #partnership #acquisition

👀 Labcorp has announced US-wide self-collection options for HPV and sexually transmitted infection (STI) testing, providing women with more convenient and private screening methods. The new services will be available at 2,200 Patient Service Centers and participating physician offices starting April 7, 2025. 🚀 💬 “Many patients delay or avoid necessary health screenings due to discomfort, stigma or time challenges, which can lead to health complications and further spread infections,” said Dr. Brian Caveney, Labcorp’s chief medical and scientific officer. “Labcorp is now offering self-collection at our PSCs and healthcare settings such as physician offices to break down these barriers. With convenient access to essential tests and screenings, patients can take control of their health, on their own terms, when it’s most convenient for them.” Brian Caveney, Chief Medical and Scientific Officer at Labcorp More on this: https://lnkd.in/g_9dXuS6 #femtech #womenshealth #womenshealthinnovation #healthtech #healthcare #healthcareinnovation #launch #innovation #hpv #sti

🚀 Mira has announced the launch of the first Hormone Innovators Awards 2025. As part of Mira’s annual Sex Hormones Awareness Week, this initiative aims to spotlight groundbreaking work, promote awareness of hormonal health challenges, and provide a platform for companies and individuals driving change in the industry. 👇 💬 “For far too long, women’s health has been underfunded, undervalued, and underserved. The innovators we’re recognizing are not only advancing groundbreaking science but also reshaping an industry that has historically overlooked half the population. By championing investment and innovation in hormonal health, we can drive lasting change for generations to come." Sylvia Kang, CEO and Founder of Mira More on this: https://lnkd.in/gFapchBG #sponsored #femtech #womenshealth #womenshealthinnovation #hormonehealth #healthcare #ecosystem #awards #healthcareinnovation #healthtech #biotech #digitalhealth